The company launched Chlorpromazine Hydrochloride, an injectable used to treat psychiatric ... the brokerage expects 11% ...

Hydrochloride for Injection, USP in two vial sizes: 25 mg/1 mL and 50 mg/2 mL, further broadening PCC's increasing portfolio of generic injectables.

Piramal Pharma said that its subsidiary Piramal Critical Care (PCC) has launched Chlorpromazine Hydrochloride for Injection in various strengths in the US market. Chlorpromazine Hydrochloride ...

A major new analysis involving more than 130million people has revealed that five types of commonly taken medications could raise the risk of dementia. Antipsychotics, some medications for high ...

Traditional solid phase extraction (SPE) revolutionized sample preparation, but it often involves high solvent consumption and complex procedures. Micro solid phase extraction (μSPE) offers a ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, or decrease, the risk that someone could be diagnosed with dementia.

Piramal Pharma Ltd on Wednesday (January 22) said its division Piramal Critical Care (PCC) has announced the US launch of Chlorpromazine Hydrochloride for Injection, USP. The product will be available ...

This came after Piramal Pharma’s division Piramal Critical Care (PCC) announced the US launch of Chlorpromazine Hydrochloride Injection which will be offered in 25mg/1mL and 50mg/2 mL vials .